Photos

The images on this website are for news media use only. If you have comments or questions, please do not hesitate to contact us.


Research and development of liraglutide at Novo Nordisk in Bagsværd, DenmarkResearch and development of liraglutide at Novo Nordisk in Bagsværd, Denmark


Download High Res
Download Low Res

Liraglutide<span class="sup">®</span> molecule - Novo NordiskLiraglutide® molecule - Novo Nordisk


Download High Res
Download Low Res

Mads Krogsgaard ThomsenMads Krogsgaard Thomsen

Executive vice president and chief science officer (CSO)


Download High Res
Download Low Res

Pen devicePen device


Download High Res
Download Low Res

Lotte Bjerre Knudsen at her laboratoryLotte Bjerre Knudsen at her laboratory

Lotte Bjerre Knudsen, who developed the liraglutide compound, pictured here in her laboratory at Novo Nordisk's R&D facility in Måløv, Denmark.


Download High Res
Download Low Res

  •  

Our positions

The Novo Nordisk business is based on a clear vision, a strong set of core values and a consistent corporate governance model.

Read more
eliminateiestendencies
  •